Bradley Campbell | President, Chief Executive Officer |
Sébastien Martel | Chief Business Officer |
Jeff Castelli | Chief Development Officer |
Daphne Quimi | Chief Financial Officer |
Andrew Faughnan | Vice President, Investor Relations |
Malcolm Kuno | JP Morgan |
Ellie Merle | UBS |
Joseph Schwartz | SVB Securities |
Athena | Cowen |
Dae Gon Ha | Stifel |
Kristen Kluska | Cantor Fitzgerald |
Shrinatra | Goldman Sachs |
Jeff Hung | Morgan Stanley |
Zhiqiang Shu | Berenberg |
Good morning ladies and gentlemen and welcome to the Amicus Therapeutics first quarter 2023 financial results conference call and webcast.
At this time, all participants are in a listen-only mode. Later we will conduct a question and answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Mr.